Form 4: Avita Medical CFO David O'Toole Acquires 150,000 Stock Options
SEC Form 4 Filing
David O'Toole, CFO of Avita Medical, Inc., acquired 150,000 stock options on January 21, 2025, vesting in three equal annual installments.
Summary
- On January 21, 2025, David O'Toole, the CFO of Avita Medical, Inc., acquired 150,000 stock options.
- The exercise price of these options is $8.73.
- The options vest in three equal annual installments, starting on the first anniversary of the grant date.
- The expiration date for these options is January 21, 2034.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the compensation structure and equity ownership of company executives.
Stakeholder Impact
- The granting of stock options aligns the CFO's interests with those of the shareholders, incentivizing him to increase the company's value.
Key Dates
| Date | Description |
|---|---|
| 01/21/2025 | Date of transaction: David O'Toole acquired 150,000 stock options. |
| 01/22/2025 | Date of Form 4 signature. |
| 01/21/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.